
Eleva, a biopharmaceutical company specialising in formerly inaccessible biologics, has announced the appointment of Dr Erich Rajkovic as Chief Business …
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board

